TAFA4-IL-10 Axis Potentiate Immunotherapy for Airway Allergy by Induction of Specific Regulatory T Cells

An allergic rhiniti (AR) mouse model was developed using ovalbumin as the specific antigen. The AR response was assessed in mice after treatment with allergen-specific immunotherapy or/and TAFA4.